Fructophilic lactic acid producing bacteria

Patent metadata

Field	Value
Publication number	US-11197898-B2
Application number	US-201916410054-A
Country	US
Kind code	B2
Filing date	May 13, 2019
Priority date	May 13, 2019
Publication date	Dec 14, 2021
Grant date	Dec 14, 2021

Abstract

The present invention discloses a novel fructophilic lactic acid producing bacteria Bacillus coagulans strain FF-7 (MTCC 25235) and the process of isolation and characterization of the bacteria. The invention also discloses the biological applications/therapeutic use of fructophilic lactic acid producing bacteria in increased utilization of fructose from food stuff and in the managing disorders related to high fructose intake.

First claim

We claim:

1. A method of increasing utilization of fructose in food stuff, said method comprising step of bringing into contact foods rich in fructose with probiotic bacteria Bacillus coagulans MTCC 25235, to bring about an effect of increased utilization of fructose or to decrease the content of fructose from foods rich in fructose.

2. The method as in claim 1 , wherein the said probiotic bacterium is isolated from honey.

3. The method as in claim 1 , wherein the foods rich in fructose are selected from the group consisting of high fructose corn syrup, honey, Agave, Maple syrup, Coconut sugar, Palm sugar, Molasses, Soda, Candies, sweetened yogurt, frozen foods, canned foods, cereals, fruit juices, coffee creamer, jams and jellies, energy drinks, condiments, ice cream.

4. The method as in claim 1 , wherein increased utilization of fructose is effective for the therapeutic management of disorders related to high fructose intake.

5. The method as in claim 4 , wherein the disorders related to high fructose intake are selected from the group consisting of, obesity, non-alcoholic steatohepatitis (NASH), insulin resistance, metabolic syndrome, cardio-vascular complications, diabetes, hyperlipidemia, hypertension, inflammation and hyperuricemia.

6. The method as in claim 1 , wherein the probiotic bacteria is present in the form of an inoculum, freeze-dried powder, fine powder, tablet, capsule, suspension, solution, emulsion, gummy, chewable or edible foods and administered as a stand alone or in combination with foods rich in fructose selected from the group consisting of high fructose corn syrup, honey, Agave, Maple syrup, Coconut sugar, Palm sugar, Molasses, Soda, Candies, sweetened yogurt, frozen foods, canned foods, cereals, fruit juices, coffee creamer, jams and jellies, energy drinks, condiments, ice cream.

Assignees

• Majeed Muhammed
• Nagabhushanam Kalyanam
• Ali Furqan
• Arumugam Sivakumar
• Majeed Shaheen
• Beede Kirankumar
• Sami Labs Ltd

Inventors

• Majeed Muhammed
• Nagabhushanam Kalyanam
• Ali Furqan
• Arumugam Sivakumar
• Majeed Shaheen
• Beede Kirankumar

Classifications

• A61P29/00

  Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

• A61K9/48

  Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)} · CPC title

• C12R2001/07

  Bacillus · CPC title

• A23L33/135

  Bacteria or derivatives thereof, e.g. probiotics · CPC title

• A61K35/742 Primary

  Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes · CPC title